FHTX
Price
$4.06
Change
-$0.26 (-6.02%)
Updated
Mar 4, 11:01 AM (EDT)
Capitalization
269.72M
2 days until earnings call
VIGL
Price
$2.17
Change
-$0.02 (-0.91%)
Updated
Mar 4, 11:37 AM (EDT)
Capitalization
98.93M
16 days until earnings call
Ad is loading...

FHTX vs VIGL

Header iconFHTX vs VIGL Comparison
Open Charts FHTX vs VIGLBanner chart's image
Foghorn Therapeutics
Price$4.06
Change-$0.26 (-6.02%)
Volume$200
Capitalization269.72M
Vigil Neuroscience
Price$2.17
Change-$0.02 (-0.91%)
Volume$100
Capitalization98.93M
FHTX vs VIGL Comparison Chart
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. VIGL commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and VIGL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (FHTX: $4.34 vs. VIGL: $2.19)
Brand notoriety: FHTX and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 78% vs. VIGL: 16%
Market capitalization -- FHTX: $269.72M vs. VIGL: $98.93M
FHTX [@Biotechnology] is valued at $269.72M. VIGL’s [@Biotechnology] market capitalization is $98.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, VIGL is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 5 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 6 bearish.
  • VIGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than FHTX.

Price Growth

FHTX (@Biotechnology) experienced а -15.89% price change this week, while VIGL (@Biotechnology) price change was -17.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -11.04%, and the average quarterly price growth was -7.19%.

Reported Earning Dates

FHTX is expected to report earnings on May 12, 2025.

VIGL is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($270M) has a higher market cap than VIGL($98.9M). VIGL YTD gains are higher at: 28.824 vs. FHTX (-8.051). VIGL has higher annual earnings (EBITDA): -87.97M vs. FHTX (-98.53M). FHTX has more cash in the bank: 267M vs. VIGL (111M). VIGL has less debt than FHTX: VIGL (13.2M) vs FHTX (39.1M). FHTX has higher revenues than VIGL: FHTX (25.5M) vs VIGL (0).
FHTXVIGLFHTX / VIGL
Capitalization270M98.9M273%
EBITDA-98.53M-87.97M112%
Gain YTD-8.05128.824-28%
P/E RatioN/AN/A-
Revenue25.5M0-
Total Cash267M111M241%
Total Debt39.1M13.2M296%
TECHNICAL ANALYSIS
Technical Analysis
FHTXVIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HBSGX25.76N/A
N/A
Hartford Small Cap Growth HLS IB
TILPX28.14N/A
N/A
Nuveen Large Cap Growth Premier
GEACX17.44N/A
N/A
GMO Resources I
TGVCX48.54N/A
N/A
Touchstone Growth Opportunities C
SPMCX7.53N/A
N/A
Saratoga Mid Capitalization C

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-10.52%
ABOS - FHTX
50%
Loosely correlated
-10.16%
AVIR - FHTX
48%
Loosely correlated
-4.13%
AURA - FHTX
44%
Loosely correlated
-3.74%
ATXS - FHTX
44%
Loosely correlated
-4.97%
XNCR - FHTX
42%
Loosely correlated
-5.60%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with ALEC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
-9.50%
ALEC - VIGL
35%
Loosely correlated
-13.41%
FHTX - VIGL
33%
Poorly correlated
-10.52%
PTGX - VIGL
32%
Poorly correlated
+2.42%
OABI - VIGL
32%
Poorly correlated
-1.58%
CLDX - VIGL
32%
Poorly correlated
-5.93%
More